MILWAUKEE, June 27, 2022 /PRNewswire/ — Ademi LLP is investigating Epizyme (NASDAQ:EPZM) for possible breaches of fiduciary duty and other violations of law in its transaction with Ipsen. Click here to learn how to join the action: https://www.ademilaw.com/case/epizyme-inc or call Guri…